Taro Pharmaceutical Industries (TARO)


Stock Price Forecast

May 20, 2022


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Taro Pharmaceutical Industries chart...

About the Company

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.

CEO

Uday Baldota

Exchange

NEW YORK STOCK EXCHANGE INC.

Website

www.taro.com

$566M

Total Revenue

1K

Employees

$1B

Market Capitalization

1253.33

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $TARO News

Taro Pharmaceuticals U.S.A., Inc. Expands OTC Portfolio for Children with the Introduction of bébé Bottoms™ Diaper Rash Crème Spray

12h ago, source:

While traditional diaper rash creams are thick, sticky, and messy, Taro's new bébé Bottoms Diaper Rash Crème Spray allows for ...

Taro Pharmaceutical Industries (TARO) Price Target Increased by 22.86% to 43.86

1mon ago, source: Fintel on MSN

The average one-year price target for Taro Pharmaceutical Industries (NYSE:TARO) has been revised to 43.86 / share. This is ...

Taro Pharmaceutical Industries Ltd

11d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro ...

1mon ago, source: Business Wire

Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Taro Pharmaceutical Industries Ltd. (NYSE: TARO) to Sun Pharmaceutical Industries Limited.

Taro Pharmaceutical Industries Ltd.

7d ago, source: Wall Street Journal

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

TARO Taro Pharmaceutical Industries Ltd.

6d ago, source: Seeking Alpha

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Taro Pharmaceutical Industries Ltd.

28d ago, source: Wall Street Journal

1 Day TARO 0.21% DJIA 0.12% S&P Mid Cap 400 0.82% Health Care/Life Sciences -0.66% ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...